Example: Heart Attack

Search clinical trials for: Quinidine gluconate

Total 58 results

NCT04464564

Not yet recruiting

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Conditions: Agitation in Patients With Dementia of the Alzheimer's Type
NCT04408755

Not yet recruiting

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Conditions: Agitation in Patients With Dementia of the Alzheimer's Type
NCT03896945

Recruiting

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Negative Symptoms of Schizophrenia

Conditions: Schizophrenia
NCT03883581

Recruiting

Impact of Nuedexta on Bulbar Physiology and Function in ALS

Conditions: Amyotrophic Lateral Sclerosis
NCT03854019

Recruiting

Evaluating the Efficacy of Dextromethorphan/Quinidine in Treating Irritability in Huntington's Disease

Conditions: Huntington Disease; Irritability
NCT03755778

Completed

Drug-Drug Interaction Study Between EDP-938, Itraconazole, Rifampin, and Quinidine in Healthy Subjects

Conditions: RSV Infection
NCT03610945

Completed

Drug-drug Interaction Study Between EDP-305, Fluconazole and Quinidine in Healthy Volunteers

Conditions: NASH - Nonalcoholic Steatohepatitis
NCT03570281

Recruiting

Edoxaban for the Treatment of Coagulopathy in Patients With Active Cancer and Acute Ischemic Stroke: a Pilot Study. (ENCHASE Study)

Conditions: Correction of Cancer-related Coagulopathy With Novel Oral Anticoagulant (Edoxaban)
NCT03489395

Recruiting

A Pilot Study on Edoxaban for the Resolution of Left Atrial Thrombosis in Patients With Non-valvular Atrial Fibrillation

Conditions: Atrial Fibrillation
NCT03420222

Terminated

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Intermittent Explosive Disorder

Conditions: Intermittent Explosive Disorder
NCT03393520

Recruiting

Assessment of the Efficacy, Safety, and Tolerability of AVP-786 (Deudextromethorphan Hydrobromide [d6-DM]/Quinidine Sulfate [Q]) for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Conditions: Agitation in Patients With Dementia of the Alzheimer's Type
NCT03381664

Completed

Study to Assess the Bioavailability, Pharmacokinetics, Safety, and Tolerability of AVP-923 in Healthy Adult Participants

Conditions: Healthy Adult Male and Female Volunteers
NCT03095066

Active, not recruiting

Study to Assess the Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Neurobehavioral Disinhibition Including Aggression, Agitation, and Irritability in Patients With Traumatic Brain Injury

Conditions: Neurobehavioral Disinhibition
NCT02860338

Completed

COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE

Conditions: Mild Cognitive Impairment; Dementia; Hypoxia; Hyperhomocysteinemia; Vitamin B 12 Deficiency; Iron Deficiency; Anemia; TBI; Neurodegenerative Disorders; Alzheimer's Disease; Vascular Dementia; Brain Injuries; Tauopathies; Parkinson's Disease; Lewy Body Dementia; Frontotemporal Dementia; TDP-43 Proteinopathies
NCT02704416

Recruiting

Ablation in Brugada Syndrome for the Prevention of VF

Conditions: Brugada Syndrome
NCT02534038

Terminated

Safety, Tolerability and Efficacy of AVP-786 for the Treatment of Disinhibition

Conditions: Disinhibition Syndrome
NCT02496039

Terminated

Effectiveness, Safety, and Health-Related Outcomes of NUEDEXTA® in Nursing Home Patients With Pseudobulbar Affect (PBA)

Conditions: Pseudobulbar Affect (Involuntary Laughing and/or Crying)
NCT02477670

Completed

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Residual Schizophrenia

Conditions: Schizophrenia
NCT02446132

Recruiting

Long Term, Extension Study of the Safety and Efficacy of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Conditions: Agitation in Patients With Dementia of the Alzheimer's Type
NCT02442765

Completed

Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Conditions: Agitation in Patients With Dementia of the Alzheimer's Type
NCT02442778

Completed

Efficacy, Safety, and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type

Conditions: Agitation in Patients With Dementia of the Alzheimer's Type
NCT02402595

Completed

Drug Interaction Study Between AVP-923 and Itraconazole and Between AVP-786 and Itraconazole in Healthy Adult Subejcts

Conditions: Healthy
NCT02336347

Completed

A Phase 1 Study Comparing AVP-786 With AVP-923

Conditions: Healthy Volunteer
NCT02174822

Completed

A Phase 1, Drug Interaction Study Between AVP-786 and Paroxetine and Between AVP-786 and Duloxetine in Healthy Subjects

Conditions: Drug-drug Interaction
NCT02174835

Completed

A Phase-1 Study to Assess the Pharmacokinetics, Safety and Tolerability of AVP-786 in Healthy Volunteers

Conditions: Healthy
NCT02176018

Completed

Nuedexta for the Prevention and Modification of Disease Progression in Episodic Migraine

Conditions: Episodic Migraine
NCT02171546

Terminated

Relative Bioavailability of Dabigatran Etexilate Capsules With and Without Quinidine Sulfate Tablets and to Measure the Effect of Quinidine on the Absorption of Fexofenadine in Healthy Male and Female Volunteers

Conditions: Healthy
NCT02171624

Completed

Safety and Pharmacokinetics of Quinidine Alone and in Combination With Dabigatran Etexilate

Conditions: Healthy
NCT02153502

Completed

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Conditions: Depressive Disorder, Treatment-Resistant
NCT01882829

Completed

Nuedexta in Treatment-Resistant Major Depression

Conditions: Major Depressive Disorder; Treatment Resistant
NCT01873950

Completed

Study of the Electrocardiographic Effects of Ranolazine, Dofetilide, Verapamil, and Quinidine in Healthy Subjects

Conditions: Drug-induced Surface ECG Changes
NCT01857622

Completed

Safety and Pharmacokinetics Study of DU-176b Administered to Non-valvular Atrial Fibrillation With Severe Renal Impairment

Conditions: Non-valvular Atrial Fibrillation
NCT01832350

Terminated

Nuedexta in the Treatment of Pseudobulbar Affect in Patients With Alzheimer's Disease

Conditions: Alzheimer's Disease; Pseudobulbar Affect (PBA)
NCT01806857

Completed

Clinical Trial Nuedexta in Subjects With ALS

Conditions: Amyotrophic Lateral Sclerosis (ALS)
NCT01799941

Completed

Safety, Tolerability and Effectiveness of Nuedexta in the Treatment of Pseudobulbar Affect (PBA)

Conditions: Pseudobulbar Affect (PBA); Stroke; Dementia; Traumatic Brain Injury (TBI)
NCT01787747

Completed

Pharmacokinetics (PK) and Tolerability of AVP-786 in Healthy Volunteers

Conditions: Healthy
NCT01767129

Completed

Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients

Conditions: Dyskinesia; Parkinson's Disease
NCT01731067

Completed

Cocktail Approach for Cytochrome P450 and P-glycoprotein Activity Assessment Using Dried Blood Spot

Conditions: Healthy Volunteers
NCT01712828

Completed

Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males

Conditions: Healthy
NCT01630811

Completed

Nuedexta for the Treatment of Adults With Autism

Conditions: Autism
NCT01584440

Completed

Efficacy, Safety and Tolerability Study of AVP-923 (Dextromethorphan/Quinidine) for Treatment of Symptoms of Agitation in Alzheimer's Patients

Conditions: Agitation; Alzheimer's Disease
NCT01533155

Completed

Study in Healthy Volunteers to Investigate the Effects of Quinidine on the Pharmacokinetics of NKTR-118

Conditions: Drug Induced Constipation
NCT01460381

Completed

A Study to Evaluate the Effect of Genotype on LY2216684

Conditions: Depressive Disorder, Major
NCT01324232

Completed

Safety and Efficacy of AVP-923 in the Treatment of Central Neuropathic Pain in Multiple Sclerosis

Conditions: Central Neuropathic Pain; Multiple Sclerosis
NCT00927732

Terminated

Hydroquinidine Versus Placebo in Patients With Brugada Syndrome

Conditions: Brugada Syndrome
NCT00911508

Completed

Catheter Ablation vs Anti-arrhythmic Drug Therapy for Atrial Fibrillation Trial

Conditions: Atrial Fibrillation; Arrhythmia
NCT00789165

Withdrawn

Empiric Quinidine for Asymptomatic Brugada Syndrome

Conditions: Arrhythmia
NCT00589303

Terminated

AV Node Ablation and Pacemaker Therapy Compared to Drug Therapy for Atrial Fibrillation - Pilot Study

Conditions: Atrial Fibrillation; Heart Failure
NCT00578617

Completed

Ablation vs Drug Therapy for Atrial Fibrillation - Pilot Trial

Conditions: Atrial Fibrillation; Arrhythmia
NCT00573443

Completed

Safety and Efficacy of AVP-923 in PBA Patients With ALS or MS

Conditions: Pseudobulbar Affect (PBA)

Search clinical trials for: Quinidine gluconate

Recent CRA jobs

CRA (Level II)

Research Scientist

Commercial Analyst - Cambridge

(Senior) Optimization Specialist - PVG, EMEA or APAC

Prin Optimization Specialist - PVG, EMEA or APAC

Compliance Specialist - Home Based

Associate Data Manager - Labs

CRA - Client-dedicated, Vaccines - Finland

Associate Director/Director, Site Intelligence and Activation (oversight)

Statistical Analyst